Recent advances in peptide-based therapy for Type 2 diabetes and obesity


The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

Publication DOI:
Divisions: College of Health & Life Sciences
Additional Information: © 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Publication ISSN: 1873-5169
Full Text Link:
Related URLs: https://linking ... 196978121001601 (Publisher URL)
PURE Output Type: Editorial
Published Date: 2021-11
Published Online Date: 2021-09-20
Accepted Date: 2021-09-01
Authors: Conlon, J. Michael
Flatt, Peter R.
Bailey, Clifford J. (ORCID Profile 0000-0002-6998-6811)



Version: Accepted Version

Access Restriction: Restricted to Repository staff only until 20 September 2022.

License: Creative Commons Attribution Non-commercial No Derivatives

Export / Share Citation


Additional statistics for this record